Robert J. More
CIK: 0001207792
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Aug 11, 2026VIR
Vir Biotechnology, Inc.
Other(J)Direct8K shares- - Aug 11, 2026VIR
Vir Biotechnology, Inc.
Other(J)Indirect8K shares- - May 28, 2026TYRA
Tyra Biosciences, Inc.
Award(A)DirectStock Option (Right to Buy)
13.2K shares- - May 27, 2026VIR
Vir Biotechnology, Inc.
Award(A)Direct8K shares- - Dec 19, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect10K shares at avg. $25.00$250K - Nov 21, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect246.9K shares at avg. $20.25$5.0M - Jun 9, 2025VIR
Vir Biotechnology, Inc.
Other(J)Indirect14K shares- - Jun 9, 2025VIR
Vir Biotechnology, Inc.
Other(J)Direct14K shares- - May 30, 2025VIR
Vir Biotechnology, Inc.
Award(A)Direct8K shares- - May 29, 2025TYRA
Tyra Biosciences, Inc.
Award(A)DirectStock Option (Right to Buy)
22.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 11, 2026 |  VIR Vir Biotechnology, Inc. | Other(J) | 8,000 | - | $0 | Direct |
| Aug 11, 2026 | VIR Vir Biotechnology, Inc. | Other(J) | 8,000 | - | $0 | Indirect |
| May 28, 2026 |  TYRA Tyra Biosciences, Inc. | Award(A) Stock Option (Right to Buy) | 13,160 | - | - | Direct |
| May 27, 2026 | VIR Vir Biotechnology, Inc. | Award(A) | 8,000 | - | $0 | Direct |
| Dec 19, 2025 | TYRA Tyra Biosciences, Inc. | Sale(S) | 10,000 | $25.00 | $250,000 | Indirect |
| Nov 21, 2025 | TYRA Tyra Biosciences, Inc. | Sale(S) | 246,871 | $20.25 | $5,000,026 | Indirect |
| Jun 9, 2025 | VIR Vir Biotechnology, Inc. | Other(J) | 14,027 | - | - | Indirect |
| Jun 9, 2025 | VIR Vir Biotechnology, Inc. | Other(J) | 14,027 | - | - | Direct |
| May 30, 2025 | VIR Vir Biotechnology, Inc. | Award(A) | 8,000 | - | - | Direct |
| May 29, 2025 | TYRA Tyra Biosciences, Inc. | Award(A) Stock Option (Right to Buy) | 22,200 | - | - | Direct |
1-10 of 10 transactions
About MORE ROBERT J
MORE ROBERT J (SEC CIK 0001207792) files insider reports with the SEC as Director of Vir Biotechnology, Inc. (VIR) and Director of Tyra Biosciences, Inc. (TYRA).
Signal8 holds 8 ownership filings by MORE ROBERT J, all Form 4s, filed between Jun 2, 2025 and Aug 12, 2026. Those filings report 10 transactions, from May 29, 2025 to Aug 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MORE ROBERT J's filings is in SAN FRANCISCO, CA.
Recent filings by MORE ROBERT J
- Aug 11, 2026: Other transactions of VIR shares (2 lines, Form 4, code J).
- May 28, 2026: Grant or award of TYRA derivative securities (Form 4, code A).
- May 27, 2026: Grant or award of VIR shares (Form 4, code A).
- Dec 19, 2025: Open-market sale of TYRA shares (Form 4, code S).
- Nov 21, 2025: Open-market sale of TYRA shares (Form 4, code S).
Other insiders filing for Vir Biotechnology, Inc. (VIR)
- Topalian Suzanne Louise, Director
- Sawaf Aziz, EVP, Chief Financial Officer
- Coughlin Timothy, Director
- Napolitano Janet, Director
- Sabatini Brent, SVP, Chief Accounting Officer
- Sigal Charles Elliott, Director